Page last updated: 2024-08-23

5,7-dihydroxytryptamine and Weight Loss

5,7-dihydroxytryptamine has been researched along with Weight Loss in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Caillé, S; Espejo, EF; Koob, GF; Stinus, L	1

Other Studies

1 other study(ies) available for 5,7-dihydroxytryptamine and Weight Loss

Article	Year
Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome. Pharmacology, biochemistry, and behavior, 2002, Volume: 72, Issue:4 Topics: 5,7-Dihydroxytryptamine; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Biogenic Amines; Clonidine; Male; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome; Weight Loss	2002

Article

Year

Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome.

Pharmacology, biochemistry, and behavior, 2002, Volume: 72, Issue:4

Topics: 5,7-Dihydroxytryptamine; Adrenergic alpha-Agonists; Animals; Behavior, Animal; Biogenic Amines; Clonidine; Male; Morphine; Morphine Dependence; Motor Activity; Naloxone; Narcotic Antagonists; Narcotics; Opioid-Related Disorders; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Serotonin; Serotonin Agents; Substance Withdrawal Syndrome; Weight Loss

2002